JP2015505536A5 - - Google Patents

Download PDF

Info

Publication number
JP2015505536A5
JP2015505536A5 JP2014553488A JP2014553488A JP2015505536A5 JP 2015505536 A5 JP2015505536 A5 JP 2015505536A5 JP 2014553488 A JP2014553488 A JP 2014553488A JP 2014553488 A JP2014553488 A JP 2014553488A JP 2015505536 A5 JP2015505536 A5 JP 2015505536A5
Authority
JP
Japan
Prior art keywords
hydrogen
alkyl
carbocyclyl
heterocyclyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014553488A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015505536A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/022304 external-priority patent/WO2013109991A1/en
Publication of JP2015505536A publication Critical patent/JP2015505536A/ja
Publication of JP2015505536A5 publication Critical patent/JP2015505536A5/ja
Pending legal-status Critical Current

Links

JP2014553488A 2012-01-20 2013-01-18 疾患の処置のための置換された複素環化合物 Pending JP2015505536A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261589108P 2012-01-20 2012-01-20
US61/589,108 2012-01-20
PCT/US2013/022304 WO2013109991A1 (en) 2012-01-20 2013-01-18 Substituted heterocyclic compounds for disease treatment

Publications (2)

Publication Number Publication Date
JP2015505536A JP2015505536A (ja) 2015-02-23
JP2015505536A5 true JP2015505536A5 (cg-RX-API-DMAC7.html) 2016-03-03

Family

ID=48799717

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014553488A Pending JP2015505536A (ja) 2012-01-20 2013-01-18 疾患の処置のための置換された複素環化合物

Country Status (6)

Country Link
US (1) US9447078B2 (cg-RX-API-DMAC7.html)
EP (1) EP2804605A4 (cg-RX-API-DMAC7.html)
JP (1) JP2015505536A (cg-RX-API-DMAC7.html)
CN (1) CN104703598A (cg-RX-API-DMAC7.html)
HK (2) HK1198514A1 (cg-RX-API-DMAC7.html)
WO (1) WO2013109991A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013109991A1 (en) 2012-01-20 2013-07-25 Acucela Inc. Substituted heterocyclic compounds for disease treatment
US9133154B2 (en) 2013-03-12 2015-09-15 Acucela Inc. Substituted 3-phenylpropylamine derivatives for the treatment of ophthalmic diseases and disorders
WO2016202935A1 (en) 2015-06-19 2016-12-22 Bayer Pharma Aktiengesellschaft Glucose transport inhibitors
US20220133671A1 (en) * 2019-02-12 2022-05-05 The Texas A&M University System Anti-fibrotic neu3 inhibitor compounds and methods of use
IL286902B2 (en) 2019-04-03 2025-03-01 Aligos Therapeutics Inc Pyrrole compounds

Family Cites Families (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH396941A (de) 1959-08-10 1965-08-15 Ciba Geigy Verfahren zur Herstellung neuer sekundärer Amine
GB884663A (en) 1958-11-06 1961-12-13 Ciba Ltd New amines and processes for their manufacture
GB1200886A (en) 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
US3509153A (en) * 1967-03-24 1970-04-28 Miles Lab 5-phenyl (or 5-phenylalkyl)-2-(omega-(4-phenyl-1-piperazinyl)alkyl)tetrazoles
DE2710997C3 (de) 1977-03-14 1980-08-14 Dr. Karl Thomae Gmbh, 7950 Biberach 4-Alkoxy carbonylamino-phenyläthanolamine, deren Herstellung und deren Verwendung als Arzneimittel
US4569354A (en) 1982-03-22 1986-02-11 Boston University Method and apparatus for measuring natural retinal fluorescence
ZA848004B (en) * 1983-10-19 1985-06-26 Hoffmann La Roche Phenoxypropanolamines
JPH0228112A (ja) 1988-04-21 1990-01-30 Kaken Pharmaceut Co Ltd 点眼用眼圧調整剤
US5135955A (en) 1988-04-25 1992-08-04 Eli Lilly And Company Propanamine derivatives
IT1240427B (it) 1990-03-02 1993-12-15 Ministero Dall Uni E Della Ric Arilpropilammine ad azione antifungina
EP0525360B1 (en) 1991-07-30 1998-03-25 Korea Research Institute Of Chemical Technology Novel phenylacetamide derivatives and processes for the preparation thereof
WO1993015045A1 (en) 1992-01-29 1993-08-05 Smithkline Beecham Corporation N-(3-phenylpropyl)oxamic acid, oxamate, and oxamide derivatives
ES2126658T3 (es) * 1992-10-21 1999-04-01 Yoshitomi Pharmaceutical Compuesto de 2-amino-1,3-propanodiol e inmunosupresor.
US5958973A (en) * 1993-09-03 1999-09-28 Gilead Sciences, Inc. Polyhydroxy benzoic acid derivatives and their use as neuraminidase inhibitors
AU679834B2 (en) 1994-01-19 1997-07-10 Byk Nederland Bv Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure
WO2001009327A2 (en) 1999-07-28 2001-02-08 Genentech, Inc. Method of preventing the injury or death of retinal cells and treating ocular diseases
US5541228A (en) 1994-10-14 1996-07-30 Bristol-Myers Squibb Co. Melatonergic agents
US5693804A (en) * 1994-11-17 1997-12-02 Molecular Geriatrics Corporation Substituted 1-aryl-3-piperazin-1'-yl propanones
JPH0940646A (ja) * 1995-07-27 1997-02-10 Yamanouchi Pharmaceut Co Ltd ベンゼン縮合環誘導体又はその塩
US5641750A (en) 1995-11-29 1997-06-24 Amgen Inc. Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product
US6878544B2 (en) 1996-04-19 2005-04-12 Neurotech Sa Retinal cell lines with extended life-span and their applications
FR2747690B1 (fr) 1996-04-19 1998-06-12 Neurotech Sa Lignees immortalisees de cellules retiniennes et leurs applications au traitement de differents troubles primaires ou secondaires ophtalmologiques ou neurologiques
US6090624A (en) 1996-04-19 2000-07-18 Brown University Research Foundation Immortalized retinal cell lines and their applications
AUPO235996A0 (en) 1996-09-16 1996-10-10 Garvan Institute Of Medical Research Method of cell culture
CA2216439A1 (en) 1996-09-25 1998-03-25 Derek Van Der Kooy Pharmaceuticals containing retinal stem cells
DE19643592A1 (de) 1996-10-22 1998-04-23 Bayer Ag Verfahren zur Herstellung von alpha-Alkoxy-alpha-trifluormethyl-arylessigsäureestern und -arylessigsäuren
US6713300B1 (en) 1997-02-27 2004-03-30 University Of Utah Research Foundation Nucleic acid and amino acid sequences for ATP-binding cassette transporter and methods of screening for agents that modify ATP-binding cassette transporter
TW593331B (en) 1997-07-25 2004-06-21 Inspire Pharmaceuticals Inc Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
US6051605A (en) 1997-08-08 2000-04-18 Warner-Lambert Company Method of treating psychosis and schizophrenia
US6171837B1 (en) 1997-09-29 2001-01-09 The Trustees Of Columbia University In The City Of New York Mouse and human 9-cis-retinol dehydrogenase
AU1996599A (en) 1997-12-05 1999-06-28 Board Of Trustees Of The Leland Stanford Junior University Long-term survival and regeneration of central nervous system neurons
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
AU2315100A (en) 1999-01-05 2000-07-24 Aventis Pharma S.A. Human adult astrocytes, their preparation and uses thereof
EP1107003A1 (en) 1999-12-09 2001-06-13 Trophos Methods for screening compounds active on neurons
US6406840B1 (en) 1999-12-17 2002-06-18 Biomosaic Systems, Inc. Cell arrays and the uses thereof
ATE319712T1 (de) 1999-12-21 2006-03-15 Mgi Gp Inc Hydantoin derivate, pharmazeutische zusammensetzungen und verfahren zu ihrer verwendung
WO2001053297A1 (en) * 2000-01-20 2001-07-26 Merck & Co., Inc. Alpha v integrin receptor antagonists
AU2001264564A1 (en) 2000-05-02 2001-11-12 Central Institute For The Deaf Composition and methods for treating photoreceptor degeneration
US20020009713A1 (en) 2000-05-11 2002-01-24 Miller Freda D. Methods for identifying modulators of neuronal growth
CN1328387C (zh) * 2000-07-13 2007-07-25 三共株式会社 氨基醇衍生物
JP2002167382A (ja) * 2000-07-13 2002-06-11 Sankyo Co Ltd アミノアルコ−ル誘導体
JP2002053575A (ja) * 2000-08-09 2002-02-19 Sankyo Co Ltd アミノアルコ−ル類
US20030032078A1 (en) 2001-01-23 2003-02-13 Board Of Regents, The University Of Texas System Methods and compositions for the treatment of macular and retinal degenerations
DE10141018A1 (de) 2001-08-22 2003-03-13 Eth Zuerich Eidgenoessische Te Verwendung von negativ geladenen Phospholipiden, sowie Zusammensetzungen umfassend Phospholipide zur Behandlung des Auges
DK1471054T3 (da) * 2002-01-11 2009-11-09 Daiichi Sankyo Co Ltd Aminoalkohol-derivat eller phosphonsyre-derivat og medicinsk sammensætning, der indeholder disse
JP4771511B2 (ja) * 2003-07-08 2011-09-14 第一三共株式会社 アミノアルコ−ル誘導体又はホスホン酸誘導体を含有する医薬組成物
EP1551956A4 (en) 2002-07-12 2006-12-27 Univ Washington METHOD AND SYSTEMS FOR THE EXTENDED IN VITRO CULTURE OF NEURONAL CELLS
DE10235312A1 (de) 2002-08-01 2004-02-12 Basf Ag Verfahren zur Herstellung von Aminoalkoxybenzylaminen und Aminoalkoxybenzonitrilen als Zwischenprodukte
WO2004052227A2 (en) 2002-12-06 2004-06-24 Alcon, Inc. Superoxide dismutase mimics for the treatment of ocular disorders and diseases
JP2006519250A (ja) * 2003-03-04 2006-08-24 ファイザー・プロダクツ・インク 医療処置におけるep2選択的受容体アゴニストの使用
JP2006520393A (ja) 2003-03-14 2006-09-07 ユニバーシティ オブ ワシントン レチノイド補充物およびオプシンアゴニスト、ならびにそれらの使用法
JP2007500509A (ja) 2003-07-30 2007-01-18 アクセラ, インコーポレイテッド 長期一次網膜細胞培養およびストレスモデル、ならびにこれらの使用方法
CA2537093C (en) 2003-08-29 2013-11-12 Ono Pharmaceutical Co., Ltd. Compound capable of binding s1p receptor and pharmaceutical use thereof
US7706863B2 (en) 2004-01-21 2010-04-27 University Of Washington Methods for assessing a physiological state of a mammalian retina
US7566808B2 (en) 2004-02-17 2009-07-28 President And Fellows Of Harvard College Management of ophthalmologic disorders, including macular degeneration
KR100859891B1 (ko) 2004-08-26 2008-09-23 화이자 인코포레이티드 단백질 키나제 억제제로서 거울상이성질체적으로 순수한아미노헤테로아릴 화합물
TWI359810B (en) * 2004-11-04 2012-03-11 Mitsubishi Tanabe Pharma Corp Carboxylic acid derivative containing thiazole rin
US20060252107A1 (en) 2005-02-22 2006-11-09 Acucela, Inc. Compositions and methods for diagnosing and treating retinal diseases
EP1867640A4 (en) * 2005-03-22 2010-07-14 Kyowa Hakko Kirin Co Ltd MEANS FOR TREATING SOLID TUMORS
US8098907B2 (en) 2005-07-01 2012-01-17 Siemens Corporation Method and system for local adaptive detection of microaneurysms in digital fundus images
TW200744567A (en) 2005-09-23 2007-12-16 Alcon Inc Phenylethylamine analogs and their use for treating glaucoma
ATE521608T1 (de) * 2005-11-01 2011-09-15 Array Biopharma Inc Glucokinaseaktivatoren
PT1966130E (pt) * 2005-12-23 2014-01-30 Zealand Pharma As Compostos miméticos de lisina modificados
CA2636601C (en) 2006-01-13 2019-03-19 Mcgill University Novel melatonin ligands having antidepressant activity as well as sleep inducing properties
US20070293548A1 (en) 2006-03-31 2007-12-20 Wang Eric Y Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases
KR101495611B1 (ko) * 2006-04-07 2015-02-25 메틸진 인코포레이티드 히스톤 데아세틸라아제의 억제제
AU2007267733B9 (en) * 2006-05-23 2011-04-21 Irm Llc Compounds and compositions as channel activating protease inhibitors
CN101534833B (zh) * 2006-07-18 2013-03-13 贝塞斯达药理学联合有限责任公司 烟碱脱敏剂及选择、测试及使用它们的方法
KR101088942B1 (ko) * 2006-07-28 2011-12-01 화이자 프로덕츠 인코포레이티드 Ep2 작용제
JP5371953B2 (ja) 2007-04-20 2013-12-18 アキュセラ インコーポレイテッド 眼の疾患及び障害を治療するスチレニル誘導体化合物
TW200906389A (en) * 2007-05-25 2009-02-16 Daiichi Sankyo Co Ltd Pharmaceutical composition comprising of therapeutic or prophylactic agents for hepatitis
CN103664637B (zh) 2007-06-29 2016-02-03 奥克塞拉有限公司 用于治疗眼科疾病和紊乱的炔基苯基衍生化合物
US7973079B2 (en) 2007-09-27 2011-07-05 Revision Therapeutics, Inc. Methods and compounds for treating retinol-related diseases
MX337100B (es) 2007-10-05 2016-02-11 Acucela Inc Compuestos alcoxi para el tratamiento de enfermedades.
EA201070504A1 (ru) * 2007-10-25 2010-12-30 Эйкеоджен, Инк. КАРБАЦЕФЕМ β-ЛАКТАМОВЫЕ АНТИБИОТИКИ
SG185939A1 (en) 2007-11-01 2012-12-28 Acucela Inc Amine derivative compounds for treating ophthalmic diseases and disorders
WO2009113637A1 (ja) * 2008-03-12 2009-09-17 東ソー株式会社 新規なチアゾール誘導体、チアゾール誘導体固定化マトリックス、及びそれらの製造方法
EA022974B1 (ru) 2008-09-05 2016-04-29 Акусела, Инк. Серосвязанные соединения для лечения офтальмологических заболеваний и расстройств
EP2340242A4 (en) 2008-10-22 2012-04-04 Acucela Inc COMPOUNDS FOR THE TREATMENT OF EYE DISEASES AND DRESSES
JP5860398B2 (ja) 2009-07-02 2016-02-16 アキュセラ インコーポレイテッド 視覚サイクルモジュレーターの薬理
GB2474120B (en) * 2009-10-01 2011-12-21 Amira Pharmaceuticals Inc Compounds as Lysophosphatidic acid receptor antagonists
WO2013109991A1 (en) 2012-01-20 2013-07-25 Acucela Inc. Substituted heterocyclic compounds for disease treatment
TW201406707A (zh) 2012-05-04 2014-02-16 Acucela Inc 用以治療糖尿病性視網膜病變及其他眼部疾病之方法

Similar Documents

Publication Publication Date Title
US20220089597A1 (en) Compounds and compositions for inhbiting the activity of shp2
ES2651162T3 (es) Antagonistas fluorados de integrina
JP2015505536A5 (cg-RX-API-DMAC7.html)
JP2019031560A5 (cg-RX-API-DMAC7.html)
RU2014151622A (ru) Композиции и способы лечения нейродегенеративных заболеваний
JP2017533968A5 (cg-RX-API-DMAC7.html)
JP2017503835A5 (cg-RX-API-DMAC7.html)
SA518391518B1 (ar) مشتقات n-] 2-(1- بنزيل ببريدين-4-يل) إيثيل[ -4-(بيرازين-2-يل)-ببرازين-1- كربوكساميد ومركبات متصلة بها كمضادات مستقبلة المسكارين 4 (m4) لمعالجة أمراض عصبية
JP2015518491A5 (cg-RX-API-DMAC7.html)
JP2012513416A5 (cg-RX-API-DMAC7.html)
EP3541813A1 (en) Heterocyclic amides as kinase inhibitors
JP2017520607A5 (cg-RX-API-DMAC7.html)
JP2016504400A5 (cg-RX-API-DMAC7.html)
JP2015521167A5 (cg-RX-API-DMAC7.html)
JP2015505296A5 (cg-RX-API-DMAC7.html)
JP2017509586A5 (cg-RX-API-DMAC7.html)
JP2014511892A5 (cg-RX-API-DMAC7.html)
JP2013523846A5 (cg-RX-API-DMAC7.html)
JP2020507589A5 (cg-RX-API-DMAC7.html)
JP2014506582A5 (cg-RX-API-DMAC7.html)
JP2016505637A5 (cg-RX-API-DMAC7.html)
JP2015508092A5 (cg-RX-API-DMAC7.html)
JP2015523546A5 (cg-RX-API-DMAC7.html)
JP2017043614A5 (cg-RX-API-DMAC7.html)
JP2023126245A (ja) Rho関連コイルドコイル含有プロテインキナーゼの阻害剤